Assessment of 1,25-dihydroxyvitamin D3 effects on Treg cells in a mouse model of systemic lupus erythematosus
- PMID: 25318538
- DOI: 10.3109/08923973.2014.968255
Assessment of 1,25-dihydroxyvitamin D3 effects on Treg cells in a mouse model of systemic lupus erythematosus
Abstract
Context: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease which is characterized by the presence of auto-reactive T cell and anti-ds DNA antibodies. Treg cells are crucial for maintaining immunologic self-tolerance and are shown to be reduced in SLE patients. 1,25-Dihydroxyvitamin D3 has immunomedulatory effects on the immune system and has recently received substantial attention.
Objective: In this study we evaluated the effects of 1,25-dihydroxyvitamin D3 on Treg cells and related cytokines in lupus-like induced mice model.
Materials and methods: Female Balb/c mice were divided into four groups: Group one: injected with PBS and Freund's adjuvant; Group two: injected with non-activated chromatin; Group three: Lupus-like disease was induced with activated chromatin; Group four: Mice were initially treated for two weeks with 1,25-dihydroxyvitamin D3 and then lupus-like disease was induced. Group five: Four mice from group one were treated with 1,25-dihydroxyvitamin D3 for two weeks after disease establishment. Ten weeks after the last injection the mice were killed and spleens were studied for Treg percentages and expression of cytokine genes.
Results: We found that treatment with 1,25-dihydroxyvitamin D3 reduces IL-6 and IL-10 mRNA expression and increases TGF-β and Foxp3 mRNA expression levels, and also enhances spleen Treg percentage.
Conclusions: The remarkable reduction of IL-6 and IL-10 gene expressions, significant enhancement of TGF-β and Foxp3 gene expressions, along with an increase in Treg cell population after oral 1,25-dihydroxyvitamin D3 administration suggest a possible role for this vitamin as a prophylactic supplement in SLE.
Keywords: 1,25 dihydroxyvitamin D3; Balb/c mice; cytokine; systemic lupus erythematosus; treg cells.
Similar articles
-
Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.Clin Exp Immunol. 2015 Aug;181(2):253-66. doi: 10.1111/cei.12639. Clin Exp Immunol. 2015. PMID: 25845911 Free PMC article.
-
Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus.Immunology. 2006 Feb;117(2):280-6. doi: 10.1111/j.1365-2567.2005.02306.x. Immunology. 2006. PMID: 16423064 Free PMC article.
-
Bcl-xL is required for the development of functional regulatory CD4 cells in lupus-afflicted mice following treatment with a tolerogenic peptide.J Autoimmun. 2010 Mar;34(2):87-95. doi: 10.1016/j.jaut.2009.06.002. Epub 2009 Jul 12. J Autoimmun. 2010. PMID: 19596183
-
Regulatory T cells in systemic lupus erythematosus.Eur J Immunol. 2015 Feb;45(2):344-55. doi: 10.1002/eji.201344280. Epub 2014 Dec 15. Eur J Immunol. 2015. PMID: 25378177 Review.
-
Regulatory T cells in systemic lupus erythematosus (SLE); role of peptide tolerance.Autoimmun Rev. 2012 Jul;11(9):611-4. doi: 10.1016/j.autrev.2011.09.008. Epub 2011 Oct 7. Autoimmun Rev. 2012. PMID: 22001419 Review.
Cited by
-
A new generation of mesenchymal stromal/stem cells differentially trained by immunoregulatory probiotics in a lupus microenvironment.Stem Cell Res Ther. 2023 Dec 10;14(1):358. doi: 10.1186/s13287-023-03578-z. Stem Cell Res Ther. 2023. PMID: 38072921 Free PMC article.
-
Nutritional Approaches to Modulate Cardiovascular Disease Risk in Systemic Lupus Erythematosus: A Literature Review.Nutrients. 2023 Feb 19;15(4):1036. doi: 10.3390/nu15041036. Nutrients. 2023. PMID: 36839394 Free PMC article. Review.
-
Diet and Systemic Lupus Erythematosus (SLE): From Supplementation to Intervention.Int J Environ Res Public Health. 2022 Sep 20;19(19):11895. doi: 10.3390/ijerph191911895. Int J Environ Res Public Health. 2022. PMID: 36231195 Free PMC article. Review.
-
Regulatory T cells in rheumatoid arthritis: functions, development, regulation, and therapeutic potential.Cell Mol Life Sci. 2022 Sep 29;79(10):533. doi: 10.1007/s00018-022-04563-0. Cell Mol Life Sci. 2022. PMID: 36173485 Free PMC article. Review.
-
The therapeutic potential of regulatory T cells in reducing cardiovascular complications in patients with severe COVID-19.Life Sci. 2022 Apr 1;294:120392. doi: 10.1016/j.lfs.2022.120392. Epub 2022 Feb 8. Life Sci. 2022. PMID: 35149115 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical